Arianna Loregian

5.5k citations

112 papers · 3.3k indexed · h-index 34

Impact in

Virology top 2%
- HIV Research and Treatment
Epidemiology top 1%
- Cytomegalovirus and herpesvirus research
- Herpesvirus Infections and Treatments
- Influenza Virus Research Studies
- Respiratory viral infections research

Papers in

Virology 16
- HIV Research and Treatment 16
Epidemiology 81
- Cytomegalovirus and herpesvirus research 37
- Herpesvirus Infections and Treatments 31
- Influenza Virus Research Studies 26

Co-authors: Giorgio Palù Beatrice Mercorelli Donald M. Coen Giulio Nannetti Laura Goracci James M. Hogle B.A. Appleton Gabriele Cruciani
Journals: Journal of Medicinal Chemistry (10 papers)European Journal of Medicinal Chemistry (9 papers)Antiviral Research (9 papers)Journal of Virology (8 papers)Antimicrobial Agents and Chemotherapy (6 papers)
Partner nations: Italy United States China

In The Last Decade

Arianna Loregian

108 papers receiving 3.2k citations

Peers

Countries citing papers authored by Arianna Loregian

Since Specialization

Citations

This map shows the geographic impact of Arianna Loregian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arianna Loregian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arianna Loregian more than expected).

Fields of papers citing papers by Arianna Loregian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arianna Loregian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arianna Loregian. The network helps show where Arianna Loregian may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Arianna Loregian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arianna Loregian Line = papers co-authored together Arianna Loregian links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Antiviral strategies against influenza virus: an update on approved and innovative therapeutic approaches Cellular and Molecular Life Sciences ·Daniela de Souza Santos, Beatrice Mercorelli, Arianna Loregian	2025	7
2	PROteolysis TArgeting Chimeras (PROTACs) and beyond: targeted degradation as a new path to fight microbial pathogens FEMS Microbiology Reviews ·Awang Saidatul Ardeenawatie, Beatrice Mercorelli, Arianna Loregian	2025	0
3	Exploring a New Generation of Pyrimidine and Pyridine Derivatives as Anti-Influenza Agents Targeting the Polymerase PA–PB1 Subunits Interaction Pharmaceutics ·I Böhne, Shinji Yokoi, Chiara Bertagnin, Daniela de Souza Santos, Valeria Francesconi, Mattia Mori, Anna Carbone, Francesca Musumeci, Arianna Loregian, Silvia Schenone	2024	1
4	Human neural progenitor cell models to study the antiviral effects and neuroprotective potential of approved and investigational human cytomegalovirus inhibitors Antiviral Research ·Marta Trevisan, 坪内奈津子, Marco Onorati, S.V. Kovalyov, Mauro Pistello, Ravit Arav‐Boger, Giorgio Palù, Beatrice Mercorelli, Arianna Loregian	2024	4
5	Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo Antiviral Research ·Daniela de Souza Santos, Jiwei Zhang, Han Ju, 赵海英, Jacqueline Melgar, Oriana Tabarrini, Serena Massari, Xinyong Liu, Beatrice Mercorelli, Peng Zhan, Arianna Loregian	2024	3
6	Elaborate Structural Modifications Yielding Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Potent Neuraminidase Inhibitors with Significantly Improved Broad-Spectrum Antiresistance Profiles Journal of Medicinal Chemistry ·Rakai Dias Rizky, Ruifang Jia, A.K. Lomholt, Ping Li, G. Wang, Daniela de Souza Santos, Chiara Bertagnin, Q. Xu, Zhou Tan, Xiuli Ma, Arianna Loregian, Bing Huang, Xinyong Liu, Peng Zhan	2024	2
7	Design, Synthesis, and Biological Evaluation of Trisubstituted Piperazine Derivatives as Noncovalent Severe Acute Respiratory Syndrome Coronavirus 2 Main Protease Inhibitors with Improved Antiviral Activity and Favorable Druggability Journal of Medicinal Chemistry ·Shenghua Gao, Takatoshi Muira, Katharina Sylvester, Beatrice Mercorelli, Arianna Loregian, Károly Tóth, 静枝藤尾, В. Ю. Иванов, Norbert Sträter, 弘燮秦, 純人田崎, Ann E. Tollefson, Christa E. Müller, Xinyong Liu, Peng Zhan	2023	15
8	Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties European Journal of Medicinal Chemistry ·Ruifang Jia, Jiwei Zhang, Fangyuan Shi, Daniela de Souza Santos, Hồ Anh Dũng, Chiara Bertagnin, Jian Zhang, Chuanfeng Liu, A.K. Lomholt, G. Wang, Xiuli Ma, Arianna Loregian, Bing Huang, Peng Zhan, Xinyong Liu	2023	6
9	Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy In Vivo mBio ·Marta Celegato, Mattia Sturlese, Vivian Vasconcelos Costa, Marta Trevisan, Kristen Smith, Feddy Setyo Pribadi, Celso Martins Queiroz‐Junior, Hanna Madziga, G. Borissov, Stefano Moro, Mauro Martins Teixeira, Arianna Loregian, Beatrice Mercorelli	2023	13
10	Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells Cancers ·Marta Celegato, Hanna Madziga, Chiara Bertagnin, Beatrice Mercorelli, Arianna Loregian	2021	15
11	Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins Acta Pharmaceutica Sinica B ·義人尾形, Ying Zhang, Han Ju, Srinivasulu Cherukupalli, Ruifang Jia, Jian Zhang, Bing Huang, Arianna Loregian, Xinyong Liu, Peng Zhan	2021	21
12	The Dimeric Form of HPV16 E6 Is Crucial to Drive YAP/TAZ Upregulation through the Targeting of hScrib Cancers ·Hanna Madziga, Marta Celegato, Chiara Bertagnin, Beatrice Mercorelli, Gualtiero Alvisi, Lawrence Banks, Giorgio Palù, Arianna Loregian	2021	11
13	Indomethacin-based PROTACs as pan-coronavirus antiviral agents European Journal of Medicinal Chemistry ·Jenny Desantis, Beatrice Mercorelli, Marta Celegato, Francis K. Akingbade, Awang Saidatul Ardeenawatie, Massimo Baroni, Lydia Siragusa, Gabriele Cruciani, Arianna Loregian, Laura Goracci	2021	72
14	Identification of C5-NH₂ Modified Oseltamivir Derivatives as Novel Influenza Neuraminidase Inhibitors with Highly Improved Antiviral Activities and Favorable Druggability Journal of Medicinal Chemistry ·Han Ju, N. Arul Murugan, 義人尾形, Ping Li, Philamon Nyamanga, Ying Zhang, Chiara Bertagnin, راشد غازى العتیبى, Dongwei Kang, Ruifang Jia, Xiuli Ma, Ruikun Du, Vasanthanathan Poongavanam, Arianna Loregian, Bing Huang, Xinyong Liu, Peng Zhan	2021	15
15	HPV-induced cancers: preclinical therapeutic advancements Expert Opinion on Investigational Drugs ·Hanna Madziga, Arianna Loregian	2021	8
16	1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors European Journal of Medicinal Chemistry ·Gabriela Ruwer Guindani, Tommaso Felicetti, Chiara Bertagnin, Cheng Qun Wu, Daniela de Souza Santos, Maria Letizia Barreca, Violetta Cecchetti, Dirk Jochmans, Steven De Jonghe, Johan Neyts, Arianna Loregian, Oriana Tabarrini, Serena Massari	2021	25
17	Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity European Journal of Medicinal Chemistry ·Ruifang Jia, Jian Zhang, Chiara Bertagnin, Srinivasulu Cherukupalli, Canagasabey, Xiao Ding, Zhuo Li, Jiwei Zhang, Han Ju, Xiuli Ma, Arianna Loregian, Bing Huang, Peng Zhan, Xinyong Liu	2020	21
18	Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant Journal of Medicinal Chemistry ·Jian Zhang, N. Arul Murugan, Ye Tian, Chiara Bertagnin, Zengjun Fang, Dongwei Kang, راشد غازى العتیبى, Langlang Tang, John C. Griddiths, Ruifang Jia, Ping Gao, Vasanthanathan Poongavanam, Arianna Loregian, Wenfang Xu, Xiuli Ma, Xiao Ding, Bing Huang, Peng Zhan, Xinyong Liu	2018	40
19	Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivatives Organic & Biomolecular Chemistry ·Serena Massari, Jenny Desantis, Giulio Nannetti, Stefano Sabatini, Sara Tortorella, Laura Goracci, Violetta Cecchetti, Arianna Loregian, Oriana Tabarrini	2017	35
20	Efficient extracellular production of hybridE. coliheat-labile enterotoxin B subunits in a marine vibrio FEMS Microbiology Letters ·Alessandro Marcello, Arianna Loregian, Gavin S. Hartnett, Timothy R. Hirst	1994	7

About Arianna Loregian

Arianna Loregian is a scholar working on Virology, Epidemiology, Parasitology, Immunology and Hepatology, having authored 112 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (37 papers), Herpesvirus Infections and Treatments (31 papers), Influenza Virus Research Studies (26 papers), HIV Research and Treatment (16 papers), RNA and protein synthesis mechanisms (15 papers), interferon and immune responses (11 papers), Toxoplasma gondii Research Studies (8 papers) and Hepatitis C virus research (8 papers). The work is most often cited by research in Virology (269 citations), Epidemiology (1.8k citations), Hepatology (259 citations), Infectious Diseases (527 citations) and Immunology (572 citations). Arianna Loregian has collaborated with scholars based in Italy, United States and China. Frequent co-authors include Giorgio Palù, Beatrice Mercorelli, Donald M. Coen, Giulio Nannetti, Laura Goracci, James M. Hogle, B.A. Appleton, Gabriele Cruciani, Giulia Muratore and H. S. Marsden. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Antiviral Research, Journal of Virology and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact